Moderna (NasdaqGS:MRNA) has expanded its collaboration with CEPI to accelerate development of an mRNA vaccine targeting ...
Mast interviewed more than two dozen former and current Moderna employees, along with analysts, rival executives, investors, and experts in mRNA and vaccines to understand how the company arrived at ...
StockStory.org on MSN
Why is Moderna (MRNA) stock rocketing higher today?
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 5.1% in the afternoon session after the stock's ...
A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...
Merck (NYSE: MRK), and Pfizer (NYSE: PFE) are among the largest pharmaceutical companies in the world. The first focuses ...
BioNTech co-founders Dr. Ugur Sahin and Dr. Ozlem Tureci in its headquarters in Germany on Jan. 3.Photograph by Dina Litovsky—Redux for TIME “No!” The doctor snapped. “Look at me!” I had been staring ...
Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 10:00 AM EDTCompany ParticipantsStéphane Bancel - CEO ...
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results